• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较两种中药“龙血竭”药物的化学成分谱和抗血小板聚集作用。

Comparison of the chemical profiles and anti-platelet aggregation effects of two "Dragon's Blood" drugs used in traditional Chinese medicine.

机构信息

School of Chinese Medicine, Hong Kong Baptist University, Hong Kong Special Administrative Region, PR China.

出版信息

J Ethnopharmacol. 2011 Jan 27;133(2):796-802. doi: 10.1016/j.jep.2010.11.008. Epub 2010 Nov 10.

DOI:10.1016/j.jep.2010.11.008
PMID:21073937
Abstract

ETHNOPHARMACOLOGICAL RELEVANCE

"Dragon's Blood" has been used as a medicine since ancient times by many cultures. In traditional Chinese medicine, the resin obtained from Daemonorops draco (RDD) and the resin from Dracaena cochinchinensis (RDC) are equally prescribed as "Dragon's Blood" for facilitating blood circulation.

AIM OF THE STUDY

To verify the traditional efficacy and elucidate the mechanism, the present study compared the chemical profiles and the pharmacological effects of two species of "Dragon's Blood" mainly used in China.

MATERIALS AND METHODS

A UPLC-MS fingerprinting method was developed to compare the chemical profiles of the two medicines. The anti-platelet aggregation effects of the two medicines induced by arachidonic acid (AA) were investigated.

RESULTS

The chemical profiles of these two species of "Dragon's Blood" were significantly different. The characteristic constituents were found to be: flavanes in RDD and stilbenes in RDC. In the in vivo platelet inhibition test, performed with the dose of 200 mg/kg on rats, the peak inhibitory effects of RDD and RDC were 35.8% and 27.6%, respectively, compared with the control group. With the in vitro concentrations of 0.2, 0.4 and 0.8 mg/ml, RDD exerted significant inhibition of aggregation by 18.7%, 20.0%, and 61.6%, respectively, and RDC exerted significant inhibition of aggregation by 13.3%, 20.2%, and 31.6%, respectively.

CONCLUSION

The fingerprinting method used here is suitable for distinguishing them. All pharmacological tests indicated that RDD was more potent than RDC against platelet aggregation.

摘要

民族药理学相关性

自古以来,许多文化都将“龙血”用作药物。在中国传统医学中,从龙舌兰(RDD)和海南龙血树(RDC)中获得的树脂都被同等地用作“龙血”,以促进血液循环。

研究目的

为了验证传统功效并阐明其机制,本研究比较了两种在中国主要使用的“龙血”的化学特征和药理作用。

材料与方法

建立了一种 UPLC-MS 指纹图谱法来比较这两种药物的化学特征。研究了两种药物对花生四烯酸(AA)诱导的血小板聚集的抑制作用。

结果

这两种“龙血”的化学特征有明显差异。特征成分分别为 RDD 中的黄烷和 RDC 中的芪类。在体内血小板抑制试验中,用 200mg/kg 剂量对大鼠进行测试,RDD 和 RDC 的最大抑制作用分别为 35.8%和 27.6%,与对照组相比。在 0.2、0.4 和 0.8mg/ml 的体外浓度下,RDD 对聚集的抑制作用分别为 18.7%、20.0%和 61.6%,RDC 对聚集的抑制作用分别为 13.3%、20.2%和 31.6%。

结论

这里使用的指纹图谱法适合区分它们。所有药理试验表明,RDD 对血小板聚集的抑制作用强于 RDC。

相似文献

1
Comparison of the chemical profiles and anti-platelet aggregation effects of two "Dragon's Blood" drugs used in traditional Chinese medicine.比较两种中药“龙血竭”药物的化学成分谱和抗血小板聚集作用。
J Ethnopharmacol. 2011 Jan 27;133(2):796-802. doi: 10.1016/j.jep.2010.11.008. Epub 2010 Nov 10.
2
Natural potential therapeutic agents of neurodegenerative diseases from the traditional herbal medicine Chinese dragon's blood.传统草药中药龙血中的神经退行性疾病天然潜在治疗剂。
J Ethnopharmacol. 2014 Mar 28;152(3):508-21. doi: 10.1016/j.jep.2014.01.032. Epub 2014 Feb 5.
3
Flavylium chromophores as species markers for dragon's blood resins from Dracaena and Daemonorops trees.黄酮类发色团作为龙血树属和麒麟竭属树木所产龙血树脂的物种标记物。
J Chromatogr A. 2008 Oct 31;1209(1-2):153-61. doi: 10.1016/j.chroma.2008.09.007. Epub 2008 Sep 7.
4
[New study on species of Chinese medicine dragon's blood].[关于中药血竭品种的新研究]
Zhongguo Zhong Yao Za Zhi. 2016 Apr;41(7):1354-1357. doi: 10.4268/cjcmm20160731.
5
Dragon's Blood extract has antithrombotic properties, affecting platelet aggregation functions and anticoagulation activities.龙血提取物具有抗血栓特性,影响血小板聚集功能和抗凝活性。
J Ethnopharmacol. 2011 May 17;135(2):510-4. doi: 10.1016/j.jep.2011.03.063. Epub 2011 Apr 2.
6
Identification and differentiation of dragon's blood in works of art using gas chromatography/mass spectrometry.利用气相色谱/质谱法鉴定和区分艺术品中的血竭。
Anal Bioanal Chem. 2010 Jun;397(3):1363-76. doi: 10.1007/s00216-010-3620-0. Epub 2010 Mar 30.
7
Chalcane-stilbene conjugates and oligomeric flavonoids from Chinese Dragon's Blood produced from Dracaena cochinchinensis.从柬埔寨龙血树中提取的中国血竭中的查尔酮 - 二苯乙烯共轭物和低聚黄酮类化合物。
Phytochemistry. 2015 Nov;119:76-82. doi: 10.1016/j.phytochem.2015.09.009. Epub 2015 Oct 8.
8
Dragon's blood: botany, chemistry and therapeutic uses.龙血:植物学、化学与治疗用途。
J Ethnopharmacol. 2008 Feb 12;115(3):361-80. doi: 10.1016/j.jep.2007.10.018. Epub 2007 Oct 22.
9
Three new flavans in dragon's blood from Daemonorops draco.来自麒麟竭的龙血中三种新的黄烷类化合物。
Nat Prod Res. 2015;29(15):1419-25. doi: 10.1080/14786419.2014.1003137. Epub 2015 Jan 20.
10
Single-step purification of dracorhodin from dragon's blood resin of Daemonorops draco using high-speed counter-current chromatography combined with pH modulation.采用高速逆流色谱结合 pH 值调制法从龙血竭树脂中一步纯化血竭素。
J Sep Sci. 2009 Dec;32(23-24):4040-7. doi: 10.1002/jssc.200900392.

引用本文的文献

1
Effects of Chinese Medicine on modulating interleukin-17-regulated macrophages in coronary heart disease.中药对冠心病中白细胞介素-17调节的巨噬细胞的调节作用。
Front Pharmacol. 2025 Apr 10;16:1499786. doi: 10.3389/fphar.2025.1499786. eCollection 2025.
2
Transient receptor potential vanilloid 1 involved in the analgesic effects of total flavonoids extracted from Longxuejie ().瞬时受体电位香草酸 1 参与了从龙血竭()中提取的总黄酮的镇痛作用。
J Tradit Chin Med. 2024 Jun;44(3):437-447. doi: 10.19852/j.cnki.jtcm.20240423.004.
3
Comprehensive metabolome characterization and comparison between two sources of Dragon's blood by integrating liquid chromatography/mass spectrometry and chemometrics.
综合代谢组学特征分析及两种血竭来源的比较,整合液相色谱/质谱联用和化学计量学方法。
Anal Bioanal Chem. 2024 Mar;416(7):1571-1587. doi: 10.1007/s00216-024-05159-2. Epub 2024 Jan 27.
4
Structural Similarities and Overlapping Activities among Dihydroflavonol 4-Reductase, Flavanone 4-Reductase, and Anthocyanidin Reductase Offer Metabolic Flexibility in the Flavonoid Pathway.二氢黄酮醇4-还原酶、黄烷酮4-还原酶和花青素还原酶之间的结构相似性及重叠活性为类黄酮途径提供了代谢灵活性。
Int J Mol Sci. 2023 Sep 9;24(18):13901. doi: 10.3390/ijms241813901.
5
Theoretical and Experimental Investigation of the Antioxidation Mechanism of Loureirin C by Radical Scavenging for Treatment of Stroke.姜黄素 C 通过清除自由基治疗中风的抗氧化机制的理论与实验研究。
Molecules. 2023 Jan 2;28(1):380. doi: 10.3390/molecules28010380.
6
Molecular Basis of the Therapeutical Potential of Clove ( L.) and Clues to Its Anti-COVID-19 Utility.丁香(L.)的治疗潜力的分子基础及其抗 COVID-19 效用的线索。
Molecules. 2021 Mar 26;26(7):1880. doi: 10.3390/molecules26071880.
7
Systems Pharmacology-Dissection of the Molecular Mechanisms of Dragon's Blood in Improving Ischemic Stroke Prognosis.系统药理学——剖析血竭改善缺血性中风预后的分子机制
Evid Based Complement Alternat Med. 2020 May 17;2020:4858201. doi: 10.1155/2020/4858201. eCollection 2020.
8
Dracohodin Perochlorate Stimulates Fibroblast Proliferation via EGFR Activation and Downstream ERK/CREB and PI3K/Akt/mTOR Pathways In Vitro.高氯酸钾通过激活表皮生长因子受体及下游的细胞外信号调节激酶/环磷腺苷效应元件结合蛋白和磷脂酰肌醇-3激酶/蛋白激酶B/哺乳动物雷帕霉素靶蛋白信号通路促进成纤维细胞增殖的体外研究。
Evid Based Complement Alternat Med. 2019 Aug 25;2019:6027186. doi: 10.1155/2019/6027186. eCollection 2019.
9
In vivo pro-angiogenic effects of dracorhodin perchlorate in zebrafish embryos: A novel bioactivity evaluation platform for commercial dragon blood samples.在斑马鱼胚胎中比洛沙嗪对血管生成的作用:商业龙血样本的新生物活性评价平台。
J Food Drug Anal. 2019 Jan;27(1):259-265. doi: 10.1016/j.jfda.2018.08.005. Epub 2018 Sep 28.
10
Preventive agents for neurodegenerative diseases from resin of Dracaena cochinchinensis attenuate LPS-induced microglia over-activation.从龙血竭中提取的神经退行性疾病预防剂可减轻 LPS 诱导的小胶质细胞过度激活。
J Nat Med. 2019 Jan;73(1):318-330. doi: 10.1007/s11418-018-1266-y. Epub 2018 Nov 13.